High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: long-term outcome and prognostic factors

2000 ◽  
Vol 79 (10) ◽  
pp. 547-555 ◽  
Author(s):  
K. Neben ◽  
S. Hohaus ◽  
H. Goldschmidt ◽  
G. Egerer ◽  
M. T. Voso ◽  
...  
2009 ◽  
Vol 89 (6) ◽  
pp. 579-584 ◽  
Author(s):  
Saulius Girnius ◽  
David C. Seldin ◽  
Martha Skinner ◽  
Kathleen T. Finn ◽  
Karen Quillen ◽  
...  

2007 ◽  
Vol 1 ◽  
pp. CMO.S435
Author(s):  
Koji Kato ◽  
Yuju Ohno ◽  
Shoshu Mitsuyama ◽  
Satoshi Toyoshima ◽  
Junichi Ito ◽  
...  

Anaplastic thyroid carcinoma (ATC) is a tumor with bad prognosis and long-term survival is very low. However, appropriate combinations of chemotherapy, surgery, and radition have been reported to potentially improve the treatment results for ATC. We describe a case of refractory ATC successfully treated with high-dose chemotherapy (HDC) followed by autologous peripheral blood stem cell transplantation (auto-PBSCT). There has not been any evidence of recurrence for 10 years after auto-PBSCT. To the best of our knowledge, this is the first case of ATC that has been followed up for a long-term period after HDC with auto-PBSCT. This case suggests that intensive therapeutic approach such as HDC with auto-PBSCT may be useful.


Sign in / Sign up

Export Citation Format

Share Document